The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-09-07
DOI
10.1038/s41598-017-11810-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis
- (2015) Andrea Mancuso et al. DIGESTIVE AND LIVER DISEASE
- Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure
- (2015) Alessandro Granito et al. DIGESTIVE AND LIVER DISEASE
- Immunosuppression Modifications Based on an Immune Response Assay
- (2015) Matteo Ravaioli et al. TRANSPLANTATION
- Metronomics: towards personalized chemotherapy?
- (2014) Nicolas André et al. Nature Reviews Clinical Oncology
- Evaluation of the immune function assay in pediatric living donor liver transplantation
- (2014) Akinari Fukuda et al. PEDIATRIC TRANSPLANTATION
- Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation
- (2013) Abhijeet Waghray et al. CLINICAL TRANSPLANTATION
- Systemic Cytotoxic Chemotherapy of Patients With Advanced Hepatocellular Carcinoma in the Era of Sorafenib Nonavailability
- (2013) Eileen L. Yoon et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study
- (2013) Carlo Sposito et al. JOURNAL OF HEPATOLOGY
- Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation
- (2013) Jan Pfeiffenberger et al. LANGENBECKS ARCHIVES OF SURGERY
- Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study
- (2013) G. Brandi et al. ONCOLOGIST
- Efficacy of capecitabine and oxaliplatin regimen for extrahepatic metastasis of hepatocellular carcinoma following local treatments
- (2013) Sheng-Li He WORLD JOURNAL OF GASTROENTEROLOGY
- Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation
- (2012) Arndt Weinmann et al. DIGESTIVE AND LIVER DISEASE
- High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation
- (2012) Katharina Staufer et al. TRANSPLANT INTERNATIONAL
- Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge
- (2012) Martin-Walter Welker et al. TRANSPLANT INTERNATIONAL
- Sorafenib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplantation?
- (2012) A. Vitale et al. TRANSPLANTATION PROCEEDINGS
- Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
- (2011) Pierre-Alain Clavien et al. LANCET ONCOLOGY
- Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy
- (2011) Alessandro Cucchetti et al. LIVER TRANSPLANTATION
- Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
- (2011) Carlos Gomez-Martin et al. LIVER TRANSPLANTATION
- Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation
- (2010) Wei-feng Tan et al. ACTA PHARMACOLOGICA SINICA
- Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients
- (2010) Romain Coriat et al. INVESTIGATIONAL NEW DRUGS
- Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation
- (2010) D. H. Yoon et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- mTOR inhibitors and sorafenib for recurrent heptocellular carcinoma after orthotopic liver transplantation
- (2010) Oliver Waidmann et al. JOURNAL OF HEPATOLOGY
- Efficacy, Tolerance, and Safety of Mammalian Target of Rapamycin Inhibitors as Rescue Immunosuppressants in Liver Transplantation
- (2009) J.M. Alamo et al. TRANSPLANTATION PROCEEDINGS
- Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors
- (2008) Marco Vivarelli et al. ANNALS OF SURGERY
- Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation
- (2008) Jeong-Ok Lee et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started